Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure.
about
Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure.Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction.
P2860
Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure.
@ast
Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure.
@en
type
label
Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure.
@ast
Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure.
@en
prefLabel
Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure.
@ast
Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure.
@en
P2093
P2860
P356
P1476
Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure.
@en
P2093
Dong-Hui Huang
Jing-Pu Shi
P2860
P304
P356
10.4103/0366-6999.177000
P407
P577
2016-05-01T00:00:00Z